Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China

Purpose Estimated glomerular filtration rate (eGFR) decline in HIV-1-infected patients exposure to tenofovir disoproxil fumarate (TDF) has been widely assessed using linear models, but nonlinear assumption is not well validated. We constructed a retrospective cohort study to assess whether eGFR decline follows nonlinearity during antiviral therapy. Patients and Methods We examined 823 (299 of TDF users and 524 of non-TDF users) treatment-naïve HIV-1-infected participants (age ≥ 17 years, initial eGFR ≥ 90 mL/min/1.73m2). Estimated GFR trajectories were compared by one-linear and piecewise-linear mixed effects models, before and after propensity score matching, respectively. Whether the incidence of renal dysfunction (reduced renal function [RRF], eGFR < 90 mL/min/1.73 m2 and rapid kidney function decline [RKFD], eGFR > −3 mL/min/1.73 m2/year) follows nonlinearity was assessed by logistic regression. Results The median follow-up time of this study was 10 (interquartile range, 2–20) months, during which 178 (21.6%) experienced RRF, and 451 (54.8%) experienced RKFD. The slopes (mL/min/1.73 m2/year) of eGFR were −5.31 (95% CI: −6.57, −4.06) before 1.40 years, 4.83 (95% CI: 1.38, 8.28) from years 1.40 to 2.30 and −3.71 (95% CI: −5.97, −1.45) after 2.30 years among TDF users. Within years 1.40–2.30, each year of TDF exposure was associated with a 78% decreased risk of RKFD (95% CI: −91%, −49%). In comparison, eGFR increased slightly at the initiation of antiviral therapy, declined after 2.15 years (−4.96; 95% CI: −5.76, −4.17) among non-TDF users. Such a progression nonlinear trajectory was missed on the assumption of one-linearity, whether in TDF or non-TDF users. Conclusion Over the piecewise mixed-effects analyses with the advantage of revealing the true nature of the exposure outcome relationships, an interesting reverse S-shaped relationship was observed. A routine screen based on nonlinearity could be more helpful for patient management.

[1]  G. Guaraldi,et al.  Kidney Disease in HIV Infection , 2019, Journal of clinical medicine.

[2]  R. Tsonaka,et al.  Pitfalls of linear regression for estimating slopes over time and how to avoid them by using linear mixed-effects models. , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  S. Kerr,et al.  Changes in renal function with long‐term exposure to antiretroviral therapy in HIV‐infected adults in Asia , 2018, Pharmacoepidemiology and drug safety.

[4]  E. Igumbor,et al.  Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study , 2017, Journal of the International AIDS Society.

[5]  J. Nachega,et al.  Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens , 2016, AIDS.

[6]  S. Ye,et al.  Application of Modified Glomerular Filtration Rate Estimation Equations in Chinese Diabetic Patients with Chronic Kidney Diseases. , 2015, West Indian medical journal.

[7]  N. Ford,et al.  Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. , 2015, The Lancet. Global health.

[8]  H. Yazaki,et al.  Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up , 2014, AIDS.

[9]  H. Khalili,et al.  Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention , 2014, European Journal of Clinical Pharmacology.

[10]  A. Muñoz,et al.  Nonlinear trajectory of GFR in children before RRT. , 2014, Journal of the American Society of Nephrology : JASN.

[11]  S. Khoo,et al.  Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity , 2014, AIDS.

[12]  C. Leen,et al.  Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure , 2014, The Journal of infectious diseases.

[13]  J. Nachega,et al.  Editorial commentary: Risks and benefits of tenofovir in the context of kidney dysfunction in sub-Saharan Africa. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  H. Trottier,et al.  Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Peter Reiss,et al.  Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. , 2013, The Journal of infectious diseases.

[16]  C. Huerta,et al.  Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case–control study , 2013, BMJ Open.

[17]  P. Easterbrook,et al.  The next generation of the World Health Organization's global antiretroviral guidance , 2013, Journal of the International AIDS Society.

[18]  Liang Li,et al.  Longitudinal progression trajectory of GFR among patients with CKD. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  R. Weber,et al.  Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir , 2012, AIDS.

[20]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[21]  M. Tonelli,et al.  Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  L. Hurley,et al.  Impact of Tenofovir on Renal Function in HIV-Infected, Antiretroviral-Naive Patients , 2010, Journal of acquired immune deficiency syndromes.

[23]  Peter C Austin,et al.  Report Card on Propensity-Score Matching in the Cardiology Literature From 2004 to 2006: A Systematic Review , 2008, Circulation. Cardiovascular quality and outcomes.

[24]  R. Ebrahimi,et al.  Pharmacokinetics and Safety of Tenofovir Disoproxil Fumarate on Coadministration With Lopinavir/Ritonavir , 2006, Journal of acquired immune deficiency syndromes.

[25]  Tom Greene,et al.  Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.

[26]  Rajeev Dehejia,et al.  Propensity Score-Matching Methods for Nonexperimental Causal Studies , 2002, Review of Economics and Statistics.

[27]  D. Rubin,et al.  Estimating and Using Propensity Scores with Partially Missing Data , 2000 .

[28]  H. Parving,et al.  Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  A. Mocroft,et al.  Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. , 2016, The lancet. HIV.

[30]  Lena Osterhagen,et al.  Multiple Imputation For Nonresponse In Surveys , 2016 .

[31]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[32]  Gfr Investigation Modification and evaluation of MDRD estimating equation for Chinese patients with chronic kidney disease , 2006 .